Wada H, Tanaka F, Yanagihara K, Ariyasu T, Fukuse T, Yokomise H, Inui K, Mizuno H, Ike O, Hitomi S
Department of Thoracic Surgery, Kyoto University, Japan.
J Thorac Cardiovasc Surg. 1996 Aug;112(2):349-55. doi: 10.1016/S0022-5223(96)70261-1.
To assess the time trends and survivals after operations for primary lung cancer, the cases of 845 consecutive patients who underwent thoracotomy between 1976 and 1990 were retrospectively reviewed by groups corresponding to year of the operation (the early period was 1976 to 1980, n = 208; the middle period was 1981 to 1985, n = 291, and the late period was 1986 to 1990, n = 346). The 5-year survivals at the early, the middle, and the late periods were 31.5%, 39.0%, and 54.0%, respectively, with significant improvement particularly at the late period (p < 0.05 for the early period vs the middle period, p < 0.01 for the early or middle period vs the late period); the improvement was caused by increase in the ratio of patients with stage I disease (20.7% at the early period, 32.0% at the middle period, 44.2% at the late period), increase in the rates of complete tumor resection with lymph node dissection (57.2%, 68.0%, 74.3%, respectively), and decrease in the rates of operation-related death (3.8%, 3.4%, 0.9%, respectively). The postoperative prognosis of patients with stage II disease at the late period (5-year survival 74.8%) showed significant improvement compared with the other periods. Moreover, the prognosis of patients with stage IIIa, pN2 disease (5-year survival 41.5%) showed significant improvement, which was caused by the significant decrease in patients with pT3 N2 M0 disease and poor prognosis.
为评估原发性肺癌手术后的时间趋势和生存率,对1976年至1990年间连续接受开胸手术的845例患者的病例,按手术年份分组进行回顾性分析(早期为1976年至1980年,n = 208;中期为1981年至1985年,n = 291;晚期为1986年至1990年,n = 346)。早期、中期和晚期的5年生存率分别为31.5%、39.0%和54.0%,特别是晚期有显著改善(早期与中期相比p < 0.05,早期或中期与晚期相比p < 0.01);改善的原因是I期疾病患者比例增加(早期为20.7%,中期为32.0%,晚期为44.2%),完整肿瘤切除加淋巴结清扫率增加(分别为57.2%、68.0%、74.3%),以及手术相关死亡率降低(分别为3.8%、3.4%、0.9%)。晚期II期疾病患者的术后预后(5年生存率74.8%)与其他时期相比有显著改善。此外,IIIa期pN2疾病患者的预后(5年生存率41.5%)有显著改善,这是由于pT3 N2 M0疾病患者和预后较差患者的显著减少所致。